IP Library Granted Patent US 8,162,918
Granted Patent B2
US 8,162,918 · App. 12/716,967 · Granted Apr 24, 2012

Gels with predetermined conductivity used in electroporation of tissue

Assignee: The Regents of the University of California
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,162,918
App. No.
12/716,967
Granted
Apr 24, 2012
Kind
B2
Abstract

Gel compositions with adjusted conductivity are disclosed which compositions are used for directing reversible electroporation and irreversible electroporation of cells and tissue. The gel compositions are also used in a similar manner in order to carry out thermotherapy on cells and tissues.

Claims (18)

1. A method of carrying out electroporation of tissue, comprising:

inserting a gel into tissue in a patient wherein the gel has a predetermined conductivity relative to a surrounding tissue the gel being a colloidal disperson;

applying current across the tissue in an amount so that cells of the tissue are subjected to electroporation;

wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when the current is applied to the tissue, substantially no current flows through the gel and the current is directed to a specific targeted area of the tissue to be electroporated.

2. The method of claim 1 , wherein the electroporation is reversible and the gel is comprised of a therapeutically active drug.

3. The method of claim 1 , wherein the conductivity of the gel is adjusted by incorporating a predetermined concentration of ions in the gel.

4. The method of claim 3 , wherein the ions are derived from NaCl in the gel.

5. The method of claim 3 , wherein the gel is inserted by injection.

6. The method of claim 1 , wherein:

(a) the gel is a hydrogel comprised of water and solid phase polymer chains; and

(b) the conductivity of the gel is adjusted by incorporating a predetermined concentration of ions in the gel.

7. A method of carrying out electroporation of tissue, comprising:

inserting a gel into tissue in a patient by injection wherein the gel has a predetermined conductivity relative to tissue surrounding the gel;

applying current across tissue in an amount so that cells of the tissue are subjected to electroporation;

wherein the conductivity of the gel is predetermined by incorporating a known concentration of ions in the gel.

8. The method of claim 7 , wherein the ions are derived from NaCl dissolved in the gel and wherein the conductivity of the gel is sufficiently below that of the surrounding tissue such that when current is applied substantially no current flows through the gel and the current is directed to a specific targeted area of tissue to be electroporated.

9. The method of claim 7 , wherein the gel is comprised of a therapeutically active drug.

10. The method of claim 7 , wherein the electroporation is reversible.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jun 20, 2016
From: UNIVERSITY OF CALIFORNIA BERKELEY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039079/0813 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2010
From: IVORRA, ANTONI; RUBINSKY, BORIS
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 024610/0480 →
Continuity (3)
Division 11872985 · Oct 16, 2007
Provisional Application 60829587 · Oct 16, 2006
Related Publication 20100160850A1 · Jun 24, 2010